US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

157.47

+1.230.79%

Volume:420.43K

Turnover:66.72M

Market Cap:531.38M

PE:- -

High:161.26

Open:157.46

Low:155.50

Close:156.24

52wk High:198.18

52wk Low:32.55

Shares:3.37M

Float Shares:3.22M

Volume Ratio:0.60

T/O Rate:13.04%

Dividend:1.34

Dividend Rate:0.85%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

COMPASS Pathways: Durable Psychedelic Therapy Profile and Clear Path to 2027 Approval Support Buy Rating

Government Work Report Highlights Commercial Health Insurance for the First Time: Where is the Trillion-Yuan Market Headed?

Oneview Healthcare to raise $21M to back AI developments

The Market Herald

Savara: Regulatory Momentum and Strong Phase 3 Data Underpin Buy Rating and $11 Upside Target

Sunway Healthcare Could Be Added to KLCI After Listing -- Market Talk

Analysts’ Top Healthcare Picks: Edgewise Therapeutics (EWTX), Sarepta Therapeutics (SRPT)

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE), Wave Life Sciences (WVE) and Telix Pharmaceuticals (OtherTLPPF)

Telix shares drop despite promising US FDA update

BlinkLab Finalises U.S. Clinical Network for Pivotal FDA Autism Diagnostic Trial

Telix Resubmits U.S. FDA Application for Glioma Imaging Agent TLX101-Px

Oneview Healthcare Raises A$19m in Upsized Placement and Launches SPP to Fund AI and Growth

Assessing Certara (CERT) Valuation After FDA PBPK Milestone And New Biosimulation Software Launches

Simply Wall St.

Corcept Therapeutics (CORT) Is Down 5.1% After FDA Relacorilant Rejection And Investor Lawsuits - What's Changed

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX) and Immutep Ltd (OtherPRRUF)

Dr. Oz Says Small Lifestyle Changes Could Save 'A Ton Of Money' In Healthcare Costs. Just Eat Better And Walk 10 To 15 Minutes A Day

Benzinga_recent_news

Analysts Conflicted on These Healthcare Names: Immutep (IMMP) and Ultragenyx Pharmaceutical (RARE)

Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Acurx Pharmaceuticals (ACXP)

'Healthcare is important to me': I'm worried about relocating to Florida from New Jersey. Are hospitals there under stress?

Analysts Offer Insights on Healthcare Companies: CareCloud (CCLD) and Kiniksa Pharmaceuticals (KNSA)

Sonic Healthcare (ASX:SHL) Valuation Check As P/S Lags History And Profitability Challenges Persist

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LABU/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":157.47,"timestamp":1773777600000,"preClose":156.24,"halted":0,"volume":420430,"delay":0,"changeRate":0.00787250384024571,"floatShares":3224486,"shares":3374486,"eps":0,"marketStatus":"Pre-Mkt","change":1.23,"latestTime":"03-18 04:53:05 EDT","open":157.46,"high":161.26,"low":155.5,"amount":66715715.926400006,"amplitude":0.036866,"askPrice":161,"askSize":300,"bidPrice":157.56,"bidSize":85,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773840600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":157.47,"sharesOutstanding":3074486,"nav":156.375,"aum":527686772.09,"dividendRate":0.0085,"bidAskSpread":0.001729,"postHourTrading":{"tag":"盘后","latestPrice":156.751,"preClose":157.47,"latestTime":"19:59 EDT","volume":3057,"amount":479906.9481,"timestamp":1773791971988,"change":-0.719,"changeRate":-0.004566,"amplitude":0.005461},"volumeRatio":0.6020457784160684,"impliedVol":1.0319,"impliedVolPercentile":0.86},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":3224486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6020457784160684,"shares":3374486,"dividePrice":1.3385,"high":161.26,"amplitude":0.036866,"preClose":156.24,"low":155.5,"week52Low":32.55,"pbRate":"--","week52High":198.18,"institutionHeld":0,"latestPrice":157.47,"committee":-0.558442,"eps":0,"divideRate":0.0085,"volume":420430,"delay":0,"ttmEps":0,"open":157.46,"prevYearClose":159.39,"prevWeekClose":148.85,"prevMonthClose":172.7,"prevQuarterClose":159.39,"fiveDayClose":171.5,"twentyDayClose":162.07,"sixtyDayClose":156.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2619354014","title":"COMPASS Pathways: Durable Psychedelic Therapy Profile and Clear Path to 2027 Approval Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2619354014","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619354014?lang=en_us&edition=fundamental","pubTime":"2026-03-16 12:15","pubTimestamp":1773634522,"startTime":"0","endTime":"0","summary":"COMPASS Pathways, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ritu Baral from TD Cowen maintained a Buy ra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/compass-pathways-durable-psychedelic-therapy-profile-and-clear-path-to-2027-approval-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/compass-pathways-durable-psychedelic-therapy-profile-and-clear-path-to-2027-approval-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","BK4585","XLV","BK4588","XBI"],"gpt_icon":0},{"id":"1185233339","title":"Government Work Report Highlights Commercial Health Insurance for the First Time: Where is the Trillion-Yuan Market Headed?","url":"https://stock-news.laohu8.com/highlight/detail?id=1185233339","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185233339?lang=en_us&edition=fundamental","pubTime":"2026-03-16 11:43","pubTimestamp":1773632624,"startTime":"0","endTime":"0","summary":"This year's Government Work Report proposed to \"accelerate the development of commercial health insurance, promote the high-quality development of innovative drugs and medical devices, and better...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","XBI","BK4585","BK4588","LABU"],"gpt_icon":0},{"id":"2619804334","title":"Oneview Healthcare to raise $21M to back AI developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2619804334","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619804334?lang=en_us&edition=fundamental","pubTime":"2026-03-16 10:29","pubTimestamp":1773628140,"startTime":"0","endTime":"0","summary":"Oneview Healthcare  has received strong support in oversubscribed commitments for a two-tranche placement to raise approximately $19 million. At the same time, the company has also announced a security purchase plan  to raise up to approximately $2 million more.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week.On Spotify, Apple, and more.Proceeds raised under those two will support the company’s pipeline of projects and advance its new AI-powered virtual patient assistant, Ovie.Oneview CEO, James Fitter, said the company is well funded to make continued improvement of the AI software development life cycle and other automation and AI initiatives to drive business efficiency.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment deci","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"markerherald_stock","url":"https://themarketonline.com.au/oneview-healthcare-to-raise-21m-to-back-ai-developments-2026-03-16/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/oneview-healthcare-to-raise-21m-to-back-ai-developments-2026-03-16/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["ONE.AU","BK4588","BK4137","LU0128526141.USD","XBI","BK4585","HCSG","XLV","BK7094","LU0029874061.USD","BK4581","LABU"],"gpt_icon":0},{"id":"2619248020","title":"Savara: Regulatory Momentum and Strong Phase 3 Data Underpin Buy Rating and $11 Upside Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2619248020","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619248020?lang=en_us&edition=fundamental","pubTime":"2026-03-16 10:25","pubTimestamp":1773627922,"startTime":"0","endTime":"0","summary":"Savara, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Francois Brisebois from LifeSci Capital reiterated...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/savara-regulatory-momentum-and-strong-phase-3-data-underpin-buy-rating-and-11-upside-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/savara-regulatory-momentum-and-strong-phase-3-data-underpin-buy-rating-and-11-upside-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","LABU","BK4581","BK4585","XBI"],"gpt_icon":0},{"id":"2619480809","title":"Sunway Healthcare Could Be Added to KLCI After Listing -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2619480809","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619480809?lang=en_us&edition=fundamental","pubTime":"2026-03-16 10:13","pubTimestamp":1773627180,"startTime":"0","endTime":"0","summary":"0213 GMT - Sunway Healthcare could be added to Malaysia's benchmark Kuala Lumpur Composite Index after its Wednesday listing if its first-day closing market capitalization exceeds the smallest existing index constituent, CIMB Securities analyst Ivy Ng Lee Fang says in a note. The listing follows the demerger from Sunway. At the IPO price of 1.45 ringgit a share, Sunway Healthcare's market value would be about 16.7 billion ringgit, compared with around 13.4 billion ringgit for QL Resources, currently the smallest KLCI component, she notes. Sunway Healthcare's potential KLCI weighting could be around 0.5%, she says, adding that any index inclusion may trigger rebalancing by funds tracking the KLCI. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","LU0029874061.USD","LU0128526141.USD","XBI","BK4585","BK4588","HCSG","BK4137","LABU"],"gpt_icon":0},{"id":"2619448180","title":"Analysts’ Top Healthcare Picks: Edgewise Therapeutics (EWTX), Sarepta Therapeutics (SRPT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619448180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619448180?lang=en_us&edition=fundamental","pubTime":"2026-03-16 07:40","pubTimestamp":1773618007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Edgewise Therapeutics (EWTX – Research Report) and S...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-edgewise-therapeutics-ewtx-sarepta-therapeutics-srpt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-edgewise-therapeutics-ewtx-sarepta-therapeutics-srpt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4539","XBI","SRPT","IE0002141913.USD","BK4139","IE00B2B36J28.USD","BK4588","EWTX","IE0009355771.USD","BK4137","SRPU","LU0029874061.USD","XLV","HCSG","IE00BJT1NW94.SGD","LU0128526141.USD","BK4007","BK4581","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LABU"],"gpt_icon":0},{"id":"2619648928","title":"Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE), Wave Life Sciences (WVE) and Telix Pharmaceuticals (OtherTLPPF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619648928","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619648928?lang=en_us&edition=fundamental","pubTime":"2026-03-16 07:30","pubTimestamp":1773617411,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Apogee Therapeutics (APGE – Research Report), Wave L...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-wave-life-sciences-wve-and-telix-pharmaceuticals-othertlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-wave-life-sciences-wve-and-telix-pharmaceuticals-othertlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","BK4588","BK4137","WVE","TLX","LU0029874061.USD","LU0128526141.USD","XLV","XBI","HCSG","LABU","BK4139","BK4007","LU0053671581.USD","APGE"],"gpt_icon":0},{"id":"2619489324","title":"Telix shares drop despite promising US FDA update","url":"https://stock-news.laohu8.com/highlight/detail?id=2619489324","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619489324?lang=en_us&edition=fundamental","pubTime":"2026-03-16 07:17","pubTimestamp":1773616628,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals Ltd  shares are on the slide on Monday morning. At the time of writing, the ASX healthcare stock is down 2.5% to $11.03. Image source: Getty Images Why are Telix Pharmaceuticals shares rising today?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/16/telix-shares-drop-despite-promising-us-fda-update/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/16/telix-shares-drop-despite-promising-us-fda-update/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["TLX.AU","BK4588","LABU","BK4585","BK7067"],"gpt_icon":0},{"id":"2619489563","title":"BlinkLab Finalises U.S. Clinical Network for Pivotal FDA Autism Diagnostic Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2619489563","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619489563?lang=en_us&edition=fundamental","pubTime":"2026-03-16 07:11","pubTimestamp":1773616289,"startTime":"0","endTime":"0","summary":"Blinklab Limited ( ($AU:BB1) ) just unveiled an announcement. BlinkLab Limited has completed onboarding of its tenth and final clinical site, the U...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/blinklab-finalises-u-s-clinical-network-for-pivotal-fda-autism-diagnostic-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/blinklab-finalises-u-s-clinical-network-for-pivotal-fda-autism-diagnostic-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"gpt_icon":0},{"id":"2619863514","title":"Telix Resubmits U.S. FDA Application for Glioma Imaging Agent TLX101-Px","url":"https://stock-news.laohu8.com/highlight/detail?id=2619863514","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619863514?lang=en_us&edition=fundamental","pubTime":"2026-03-16 06:08","pubTimestamp":1773612488,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) has issued an announcement. Telix Pharmaceuticals has resubmitted a New Drug Application to the U.S. FDA for TL...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-resubmits-u-s-fda-application-for-glioma-imaging-agent-tlx101-px?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-resubmits-u-s-fda-application-for-glioma-imaging-agent-tlx101-px?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX","LABU","BK4585","BK4588"],"gpt_icon":0},{"id":"2619485260","title":"Oneview Healthcare Raises A$19m in Upsized Placement and Launches SPP to Fund AI and Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2619485260","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619485260?lang=en_us&edition=fundamental","pubTime":"2026-03-16 05:45","pubTimestamp":1773611113,"startTime":"0","endTime":"0","summary":"An announcement from Oneview Healthcare Chess Depository Interests repr 1 ( ($AU:ONE) ) is now available. Oneview Healthcare has secured commitment...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oneview-healthcare-raises-a19m-in-upsized-placement-and-launches-spp-to-fund-ai-and-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oneview-healthcare-raises-a19m-in-upsized-placement-and-launches-spp-to-fund-ai-and-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","HCSG","BK4588","BK4581","LABU","XBI","BK4585","LU0128526141.USD","LU0029874061.USD","XLV"],"gpt_icon":0},{"id":"2619860674","title":"Assessing Certara (CERT) Valuation After FDA PBPK Milestone And New Biosimulation Software Launches","url":"https://stock-news.laohu8.com/highlight/detail?id=2619860674","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619860674?lang=en_us&edition=fundamental","pubTime":"2026-03-16 05:15","pubTimestamp":1773609333,"startTime":"0","endTime":"0","summary":"Certara (CERT) is back on investors’ radar after closing 2025 with revenue of US$418.8m, a small net loss, and fresh FDA validation of its biosimulation platform through PBPK modeling used in the asciminib NDA.\nSee our latest analysis for Certara.\nDespite FDA validation for its PBPK work and new software launches, Certara’s share price has been under pressure, with a 90 day share price return of 23.91% and a 1 year total shareholder return of 39.10%. This may indicate fading momentum after...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-cert/certara/news/assessing-certara-cert-valuation-after-fda-pbpk-milestone-an-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-cert/certara/news/assessing-certara-cert-valuation-after-fda-pbpk-milestone-an-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","BK4167","CERT","LABU"],"gpt_icon":0},{"id":"2619104129","title":"Corcept Therapeutics (CORT) Is Down 5.1% After FDA Relacorilant Rejection And Investor Lawsuits - What's Changed","url":"https://stock-news.laohu8.com/highlight/detail?id=2619104129","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619104129?lang=en_us&edition=fundamental","pubTime":"2026-03-15 21:22","pubTimestamp":1773580933,"startTime":"0","endTime":"0","summary":"In late 2025, Corcept Therapeutics received a Complete Response Letter from the FDA rejecting its New Drug Application for relacorilant on the grounds of insufficient evidence of effectiveness, prompting multiple securities class action lawsuits alleging the company misrepresented the drug’s regulatory prospects and prior FDA feedback.\nThese lawsuits focus not just on the setback for relacorilant, but on claims that Corcept withheld repeated FDA concerns while continuing to promote the drug...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/corcept-therapeutics-cort-is-down-51-after-fda-relacorilant","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/corcept-therapeutics-cort-is-down-51-after-fda-relacorilant","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1559883803.SGD","BK4007","BK4532","LU0566484027.USD","CORT","LABU","BK4588","BK4585"],"gpt_icon":0},{"id":"2619109621","title":"Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX) and Immutep Ltd (OtherPRRUF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619109621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619109621?lang=en_us&edition=fundamental","pubTime":"2026-03-15 20:30","pubTimestamp":1773577808,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lineage Therap (LCTX – Research Report) and Immutep Ltd (PRRUF – ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-lineage-therap-lctx-and-immutep-ltd-otherprruf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-lineage-therap-lctx-and-immutep-ltd-otherprruf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LCTX","XBI","BK4588","BK4139","LU0029874061.USD","BK4137","HCSG","XLV","BK4585","LABU","BK4581"],"gpt_icon":0},{"id":"2619176831","title":"Dr. Oz Says Small Lifestyle Changes Could Save 'A Ton Of Money' In Healthcare Costs. Just Eat Better And Walk 10 To 15 Minutes A Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2619176831","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619176831?lang=en_us&edition=fundamental","pubTime":"2026-03-15 06:31","pubTimestamp":1773527460,"startTime":"0","endTime":"0","summary":"Small changes to daily habits could dramatically lower health care costs in the U.S., according to Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz.Speaking in a recent interview on New York’s WABC-AM, Oz said Americans don't need extreme lifestyle changes to improve health outcomes and reduce the financial strain on the country's health system.The longtime heart surgeon said the solution can be surprisingly simple.“If we get the average person right now walking around New York to eat a little better today and just walk 10, 15 minutes a day, that saves us a ton of money,” Oz said. “And you’re healthy enough to watch your grandkids graduate from high school.”“The way we win the battle on health expenses in America, the way we make it more affordable is to get healthier as a people,” Oz told WABC-AM.“You’re basically paying people to do things they would have done anyway,” he said.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/14/Dr--Oz-Urges-Americans-To-Delay-Retireme.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/14/Dr--Oz-Urges-Americans-To-Delay-Retireme.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/topics/26/03/51258776/dr-oz-says-small-lifestyle-changes-could-save-a-ton-of-money-in-healthcare-costs-just-eat-better-and-walk-10-to-15-minutes-a-day","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/topics/26/03/51258776/dr-oz-says-small-lifestyle-changes-could-save-a-ton-of-money-in-healthcare-costs-just-eat-better-and-walk-10-to-15-minutes-a-day","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4581","LU0128526141.USD","XBI","LU0029874061.USD","HCSG","TON.USD.CC","BK4588","BK4585","XLV","LABU","BK4137"],"gpt_icon":0},{"id":"2619227101","title":"Analysts Conflicted on These Healthcare Names: Immutep (IMMP) and Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619227101","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619227101?lang=en_us&edition=fundamental","pubTime":"2026-03-15 00:20","pubTimestamp":1773505230,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Immutep (IMMP – Research Report) and Ultragenyx Pharmaceutical (R...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-immutep-immp-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-immutep-immp-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMMP","BK4588","XLV","LU0128526141.USD","RARE","XBI","BK4139","LABU","LU0029874061.USD","BK4137","BK4581","BK4585","HCSG"],"gpt_icon":0},{"id":"2619812269","title":"Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Acurx Pharmaceuticals (ACXP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619812269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619812269?lang=en_us&edition=fundamental","pubTime":"2026-03-14 23:50","pubTimestamp":1773503409,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Nuvalent (NUVL – Research Report) and Acurx Pharmace...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-nuvalent-nuvl-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-nuvalent-nuvl-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL","BK4563","BLSG","BLSX","BK4581","XBI","BK4139","BK4539","BK4588","LU0128526141.USD","LU0029874061.USD","BK4137","BK4585","BK4112","ACXP","LABU"],"gpt_icon":0},{"id":"2619121707","title":"'Healthcare is important to me': I'm worried about relocating to Florida from New Jersey. Are hospitals there under stress?","url":"https://stock-news.laohu8.com/highlight/detail?id=2619121707","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619121707?lang=en_us&edition=fundamental","pubTime":"2026-03-14 22:00","pubTimestamp":1773496800,"startTime":"0","endTime":"0","summary":"MW 'Healthcare is important to me': I'm worried about relocating to Florida from New Jersey. Are hospitals there under stress?'The issue is not the weather, high insurance premiums or rising maintenance fees'. \"The hospitals in the New York/New Jersey area are outstanding.\" . I'm considering relocating from New Jersey to Florida, condo to condo. The cost of living - especially property taxes - can be challenging here. When you no longer have children in the school system, it's hard to justify the high property taxes in certain towns.The hospitals in the New York/New Jersey area are outstanding. As a senior, healthcare is important to me, and I'm thinking twice about moving. Unfortunately, I cannot afford to maintain two residences. I would welcome hearing your thoughts.Metropolitan areas tend to be better served. \"Rural hospitals continue to operate under significant financial pressure, with margins well below the national median and a growing share at immediate risk of closure,\" Medic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","BK4588","BK4137","LU0029874061.USD","LU0128526141.USD","XBI","HCSG","LABU","XLV"],"gpt_icon":0},{"id":"2619291221","title":"Analysts Offer Insights on Healthcare Companies: CareCloud (CCLD) and Kiniksa Pharmaceuticals (KNSA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619291221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619291221?lang=en_us&edition=fundamental","pubTime":"2026-03-14 20:11","pubTimestamp":1773490260,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CareCloud (CCLD – Research Report) and Kiniksa Pharm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-carecloud-ccld-and-kiniksa-pharmaceuticals-knsa-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-carecloud-ccld-and-kiniksa-pharmaceuticals-knsa-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","CCLD","BK4167","BK4585","LU0029874061.USD","KNSA","BK4588","XLV","LABU","BK4137","XBI","HCSG","BK4581","BK4139","BK4505"],"gpt_icon":0},{"id":"2619308126","title":"Sonic Healthcare (ASX:SHL) Valuation Check As P/S Lags History And Profitability Challenges Persist","url":"https://stock-news.laohu8.com/highlight/detail?id=2619308126","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619308126?lang=en_us&edition=fundamental","pubTime":"2026-03-14 17:35","pubTimestamp":1773480933,"startTime":"0","endTime":"0","summary":"Event overview and why Sonic Healthcare is on watch\nRecent coverage has put Sonic Healthcare (ASX:SHL) in focus after its shares moved below the company’s historical P/S levels, while revenue growth has coincided with ongoing profitability challenges that are drawing close attention from investors.\nSee our latest analysis for Sonic Healthcare.\nAt around A$21.20, Sonic Healthcare’s recent share price return has been weak, with a 7 day share price return of 7.02% and a 1 year total shareholder...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-shl/sonic-healthcare-shares/news/sonic-healthcare-asxshl-valuation-check-as-ps-lags-history-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-shl/sonic-healthcare-shares/news/sonic-healthcare-asxshl-valuation-check-as-ps-lags-history-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7124","SHL.AU","BK4588","XLV","LABU","XBI","BK4581","BK4585"],"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":5,"totalSize":416,"code":"91000000","status":"200"}]}}